Pamlab LLC Release: AAPA Poster Presentation Explores Connection between Biomarkers and Science-Based Personalized Nutrition Therapy in the Management of Major Depressive Disorder
6/10/2013 10:07:47 AM
More...
|
Pamlab LLC Release: New Discoveries Exploring the Role of Genetic Markers in Depression Management Presented at Leading Scientific Meetings in Florida
5/31/2013 2:56:32 PM
More...
|
Pamlab LLC: New Research Highlights Biological and Genetic Markers Associated With Improved Response to Adjunctive L-Methylfolate in Management of Depression
5/23/2013 11:13:58 AM
More...
|
Pamlab LLC Release: Breakthrough Study Shows Benefits of Adjunctive L-methylfolate in the Treatment of SSRI-Resistant Major Depressive Disorder
12/18/2012 9:02:35 AM
More...
|
Pamlab LLC Release: Metanx® Study Published in the American Journal of Pharmacy Benefits Indicates Treatment Lowers the Risk of Hospitalization and Decreases Disease-Related Costs
11/19/2012 9:10:13 AM
More...
|
Pamlab LLC Release: New Studies Presented at the 2012 U.S. Psychiatric and Mental Health Congress Explore the Role of L-Methylfolate in Antidepressant Therapy
11/8/2012 10:08:11 AM
More...
|
Pamlab LLC and Breckenridge Pharmaceutical, Inc. Announce Joint Venture to Provide Authorized Generics on Pamlab Branded Medical Food Products
10/2/2012 9:57:27 AM
More...
|
Pamlab LLC Release: Study Published in Diabetes Journal, Indicates Alleviation in Diabetes-Induced Large and Small Fiber Neuropathies in Rats with Prescription Medical Food
7/9/2012 9:54:28 AM
More...
|
Pamlab LLC Release: Data Affirms Long Term Benefit of Adding L-methylfolate to Antidepressants
5/8/2012 10:38:38 AM
More...
|
Pernix Therapeutics, Inc. (PTX)’ Subsidiary Macoven Pharmaceuticals, LLC Named in Suit by Merck, Pamlab LLC and Others for Alleged Patent Violations
3/7/2012 6:16:51 AM
More...
|
|